Claudin-5 participates in the regulation of endothelial cell motility

Molecular and Cellular Biochemistry

Volumn 362, Issue 1-2, 2012, Pages 71-85

  Escudero Esparza, Astrid ^a   Jiang, Wen G ^a   Martin, Tracey A ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Claudin 5; Endothelial; N WASP; ROCK

Indexed keywords

CARRIER PROTEIN; CLAUDIN 5; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; ROCK PROTEIN; UNCLASSIFIED DRUG; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 681660 1 MG; PROTEIN INHIBITOR; WISKOSTATIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE INSERTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TIGHT JUNCTION; CELL LINE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; GENE SILENCING; HUMAN TISSUE; SIGNAL TRANSDUCTION;

CELL ADHESION; CELL LINE; CELL MOVEMENT; CLAUDINS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; WISKOTT-ALDRICH SYNDROME PROTEIN, NEURONAL;

EID: 84857056370     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1129-2     Document Type: Article

References (31)

1. Cereijido M, Contreras RG, Shoshani L, Flores-Benitez D, Larre I (2008) Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta 1778(3):770-793 (Pubitemid 351317802)
2. Martin TA, Das T, Mansel RE, Jiang WG (2006) Synergistic regulation of endothelial tight junctions by antioxidant (Se) and polyunsaturated lipid (GLA) via claudin-5 modulation. J Cell Biochem 98(5):1308-1319 (Pubitemid 44128368)
3. Paschoud S, Bongiovanni M, Pache JC, Citi S (2007) Claudin-1 and claudin-5 expression patterns differentiate lung squamous cell carcinomas from adenocarcinomas. Mod Pathol 20(9):947-954 (Pubitemid 47267821)
4. Turunen M, Talvensaari-Mattila A, Soini Y, Santala M (2009) Claudin-5 overexpression correlates with aggressive behavior in serous ovarian adenocarcinoma. Anticancer Res 29(12):5185-5189
5. Tsukita S, Furuse M (2000) Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149(1):13-16 (Pubitemid 30196694)
6. Ohkubo T, Ozawa M (2004) The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J Cell Sci 117(Pt 9):1675-1685 (Pubitemid 38559300)
7. Morita K, Furuse M, Fujimoto K, Tsukita S (1999) Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci USA 96(2):511-516 (Pubitemid 29061239)
8. Furuse M, Sasaki H, Tsukita S (1999) Manner of interaction of heterogeneous claudin species within and between tight junction strands. J Cell Biol 147(4):891-903
9. Tsukita S (1989) Isolation of cell-to-cell adherens junctions from rat liver. J Cell Biol 108(1):31-41 (Pubitemid 19050603)
10. Van Itallie CM, Anderson JM (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403-429
11. Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147(1):185-194 (Pubitemid 30211806)
12. Rahner C, Mitic LL, Anderson JM (2001) Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120(2): 411-422 (Pubitemid 32147639)
13. Amasheh S, Schmidt T, Mahn M, Florian P, Mankertz J, Tavalali S, Gitter AH, Schulzke JD, Fromm M (2005) Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells. Cell Tissue Res 321(1):89-96 (Pubitemid 40984842)
14. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161(3):653-660 (Pubitemid 36578587)
15. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B (2003) Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105(6):586-592 (Pubitemid 36798859)
16. Jiang WG, Davies G, Martin TA, Parr C, Watkins G, Mason MD, Mokbel K, Mansel RE (2005) Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy. Clin Cancer Res 11(16):6012-6019 (Pubitemid 41170333)
17. Martin TA, Pereira G, Watkins G, Mansel RE, Jiang WG (2008) N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer. Clin Exp Metastasis 25(2):97-108
18. Hiscox S, Jiang WG (1999) Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem Biophys Res Commun 261(2):406-411 (Pubitemid 29392489)
19. Sanders AJ, Guo X, Mason MD, Jiang WG (2010) IL-17B can impact on endothelial cellular traits linked to tumour angiogenesis. J Oncol 81:73-75
20. Martin TA, Harrison GM, Watkins G, Jiang WG (2008) Claudin- 16 reduces the aggressive behavior of human breast cancer cells. J Cell Biochem 105(1):41-52
21. Jiang WG, Hiscox S, Hallett MB, Scott C, Horrobin DF, Puntis MC (1995) Inhibition of hepatocyte growth factor-induced motility and in vitro invasion of human colon cancer cells by gamma-linolenic acid. Br J Cancer 71(4):744-752
22. Keese CR, Wegener J, Walker SR, Giaever I (2004) Electrical wound-healing assay for cells in vitro. Proc Natl Acad Sci USA 101(6):1554-1559 (Pubitemid 38234193)
23. Mitchison TJ, Cramer LP (1996) Actin-based cell motility and cell locomotion. Cell 84(3):371-379 (Pubitemid 26058562)
24. Mitchison TJ, Cramer LP (1996) Loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161(3):653-660
25. Short SM, Talbott GA, Juliano RL (1998) Integrin-mediated signaling events in human endothelial cells. Mol Biol Cell 9(8): 1969-1980 (Pubitemid 28373618)
26. Arnaoutova I, George J, Kleinman HK, Benton G (2009) The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis 12(3): 267-274
27. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T (2005) Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol 53(1):35-69 (Pubitemid 39656109)
28. Dovas A, Cox D (2010) Regulation of WASp by phosphorylation: activation or other functions? Commun Integr Biol 3(2):101-105
29. Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG (2008) The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 33(3):585-593
30. Osiak AE, Zenner G, Linder S (2005) Subconfluent endothelial cells form podosomes downstream of cytokine and RhoGTPase signaling. Exp Cell Res 307(2):342-353 (Pubitemid 40799360)
31. Li B, Zhao WD, Tan ZM, Fang WG, Zhu L, Chen YH (2006) Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 580(17):4252-4260 (Pubitemid 44037578)